title: Risks of inhibitors from recombinant factor VIII: a quarter of a century to reach the conclusion.
authors: Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan. thburnouf@gmail.com.
authors: T
authors: T
authors: Burnouf
authors: International Plasma Fractionation Association, Amsterdam, The Netherlands.
authors: P F W
authors: PF
authors: Strengers
mesh_terms: D000906:Antibodies / Q000097:blood*; D003029:Coagulants / Q000009:adverse effects / Q000276:immunology*; D019317:Evidence-Based Medicine; D005169:Factor VIII / Q000009:adverse effects / Q000276:immunology*; D006467:Hemophilia A / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D006801:Humans
chemical_list: D000906:Antibodies; D003029:Coagulants; C078147:F8 protein, human; D005169:Factor VIII